Brad Morie
Senior Director, Biotechnologies
Morie manages the licensing of RCT’s biotechnology licensing programs including Pichia Classic, Pichia GlycoSwitch®, ClearColi™ and other protein expression platforms. Prior to RCT, Morie was the Sr. Director, Business Development & Licensing at Ajinomoto Bio-Pharma Services where he was responsible for the global licensing of intellectual property portfolios.
Professional Experience
- Ajinomoto Bio-Pharma Services Sr. Director, Business Dev & Licensing 2014-2019
- Medigen USA, Member, Board of Advisors 2014-2019
- Catalent Pharma Solutions, Account Director, Business Development 2013-2014
- Lonza AG, Director, Business Development & Licensing 2010-2013
- BIOCRATES life sciences AG, Director of BD & Marketing 2006-2010
- Los Alamos National Laboratory, Bus Dev Exec -Tech Transfer Division 2003-2006
Education
University of North Carolina – Chapel Hill, NC
Kenan-Flagler Business School, Master of Business Administration
Wake Forest University – Winston-Salem, NC
BS – Chemistry, BA – German
Contact
Brad Morie
Assistant: Andrea Lance
(520) 748-4468
General: (520) 748-4400